Results 61 to 70 of about 46,198 (239)

Mosaic activation of the zebrafish hsp70l heat shock promoter: Implications for interpreting transgenes

open access: yesDevelopmental Dynamics, EarlyView.
Abstract Background The promoters and enhancers of heat shock genes, such as the 1.5‐kb promoter of the zebrafish hsp70l gene, are valuable tools for temporal activation of transgenes. It has been widely purported that heat shock treatments result in ubiquitous expression of hsp70l‐driven transgenes.
Jong‐Su Park, Xiangyun Wei
wiley   +1 more source

Hydroxyurea-induced Melanonychia: A Rare Case Report and Review of the Literature

open access: yes, 2023
Supplemental Table S1: Hydroxyurea-Induced Melanonychia in Patients with ThrombocytosisThis table provides a comprehensive overview of case reports on patients diagnosed with thrombocytosis and treated with hydroxyurea, detailing the emergence of ...
Buontempo, M (via Mendeley Data)   +1 more
core   +1 more source

The modern use of hydroxyurea for children with sickle cell anemia

open access: yesHaematologica
Over the past 40 years, the introduction and refinement of hydroxyurea therapy has led to remarkable progress for the care of individuals with sickle cell anemia (SCA).
Charles T. Quinn, Russell E. Ware
doaj   +1 more source

Hydroxyurea

open access: yesCold Spring Harbor Protocols, 2006
europepmc   +3 more sources

Exploring barriers and strategies for hydroxyurea uptake using the CFIR–ERIC framework: A qualitative study of sickle cell disease in India

open access: yesClinical Epidemiology and Global Health
Problem considered: Hydroxyurea therapy is the cornerstone in treating sickle cell disease (SCD). However, the adherence to hydroxyurea by individuals with SCD is limited, owing to several barriers at multiple levels.
Vandana Mullakkal Venugopalan   +5 more
doaj   +1 more source

Influence of sickle cell disease and treatment with hydroxyurea on sperm parameters and fertility of human males

open access: yesHaematologica, 2008
Background Recent progress in the treatment of sickle cell disease, in particular the use of hydroxyurea, has considerably modified the prognosis of this disease. Many more patients now reach reproductive age.
Isabelle Berthaut   +12 more
doaj   +1 more source

Nail Toxicities Associated With Anticancer Therapies in Children

open access: yesJEADV Clinical Practice, EarlyView.
ABSTRACT Nail toxicities are a frequent yet often underrecognized component of dermatologic adverse events in children receiving anticancer therapies. Both conventional cytotoxic chemotherapy and newer targeted agents can affect the nail matrix, nail bed and periungual tissues, producing a broad spectrum of clinical manifestations that range from ...
Luca Rapparini, Michela Starace
wiley   +1 more source

Hydroxyurea utilization among individuals with sickle cell disease in Tennessee: a pooled analysis of claims data

open access: yesFrontiers in Pharmacology
ImportanceHydroxyurea reduces severe disease among individuals living with sickle cell disease (SCD). These individuals experience high acute care utilization, but the associations between patterns of hydroxyurea utilization and healthcare utilization ...
Ayesha Mukhopadhyay   +14 more
doaj   +1 more source

Hydroxyurea and blood transfusion therapy for Sickle cell disease in South Asia: inconsistent treatment of a neglected disease

open access: yesOrphanet Journal of Rare Diseases, 2021
Background Hydroxyurea and blood transfusion therapies remain the main therapeutic strategies for Sickle cell disease. Preliminary data suggest substantial variation and inconsistencies in practice of these two therapeutic modalities in South Asia.
Thamal Darshana   +2 more
doaj   +1 more source

Prenatal Exome Sequencing Identifies Dual Maternal‐Fetal Diagnosis of HbF Mission Bay, a Novel HBG2 Variant Associated With Methemoglobinemia, Hypoxia and Hemolytic Anemia

open access: yesPrenatal Diagnosis, EarlyView.
ABSTRACT Prenatal exome sequencing (ES) can establish rare genetic diagnoses in a fetus but may also lead to occult genetic diagnosis in a biological parent. We present a case of dual fetal and maternal diagnosis by prenatal ES, in a fetus with unexplained anemia and in a pregnant patient with sickle cell disease (SCD) and recurrent unexplained hypoxia.
Matthew A. Shear   +6 more
wiley   +1 more source

Home - About - Disclaimer - Privacy